UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Associations between polygenic loading, psychosis liability, and clozapine use

European psychiatry, 2023-03, Vol.66 (S1), p.S82-S83

Luykx, J.

2023

Volltextzugriff (PDF)

Psychotropic drugs and the environment: a comprehensive analysis of surface water concentrations and associated risks

European psychiatry, 2023-03, Vol.66 (S1), p.S751-S752

Luykx, J.

2023

Volltextzugriff (PDF)

The genetic basis of major depression

Psychological medicine, 2021-10, Vol.51 (13), p.2217-2230

2021

Volltextzugriff (PDF)

Stratified psychiatry: Tomorrow's precision psychiatry?

European neuropsychopharmacology, 2022-02, Vol.55, p.14-19

2022

Volltextzugriff (PDF)

In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine

British journal of psychiatry, 2020-09, Vol.217 (3), p.498-505

2020

Volltextzugriff (PDF)

Clozapine as a first‐ or second‐line treatment in schizophrenia: a systematic review and meta‐analysis

Acta psychiatrica Scandinavica, 2018-10, Vol.138 (4), p.281-288

2018

Volltextzugriff (PDF)

Isolated nausea and vomiting as the cardinal presenting symptoms of clozapine-induced myocarditis: a case report

BMC psychiatry, 2020-11, Vol.20 (1), p.568-5, Article 568

2020

Volltextzugriff (PDF)

Morbidity and mortality in schizophrenia with comorbid substance use disorders

Acta psychiatrica Scandinavica, 2021-07, Vol.144 (1), p.42-49

2021

Volltextzugriff (PDF)

Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials

JAMA psychiatry (Chicago, Ill.), 2022-03, Vol.79 (3), p.210

2022

Volltextzugriff (PDF)

Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts

British journal of psychiatry, 2022-12, Vol.221 (6), p.758-765

2022

Volltextzugriff (PDF)

Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia

JAMA psychiatry (Chicago, Ill.), 2024-06

2024

Volltextzugriff (PDF)

Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia

Schizophrenia bulletin, 2022-06, Vol.48 (4), p.774-784

2022

Volltextzugriff (PDF)

Are psychiatric disorders risk factors for COVID-19 susceptibility and severity? a two-sample, bidirectional, univariable, and multivariable Mendelian Randomization study

Translational psychiatry, 2021-04, Vol.11 (1), p.210-210, Article 210

2021

Volltextzugriff (PDF)

Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid

Molecular psychiatry, 2014-02, Vol.19 (2), p.228-234

2014

Volltextzugriff (PDF)

Adjusting for population stratification in polygenic risk score analyses: a guide for model specifications in the UK Biobank

Journal of human genetics, 2023-09, Vol.68 (9), p.653-656

2023

Volltextzugriff (PDF)

Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians’ attitudes to sociocultural differences between patients across the globe

Translational psychiatry, 2022-10, Vol.12 (1), p.442-10, Article 442

2022

Volltextzugriff (PDF)

EPA-0868 – Genetic determinants of monoamine turnover in human cerebrospinal fluid: associations with 5-HT seasonality and mood symptoms

European psychiatry, 2014, Vol.29, p.1-1

Luykx, J

2014

Volltextzugriff (PDF)

EPA-0871 – Genome-wide association study of NMDA receptor coagonists in cerebrospinal fluid and plasma identifies metabolic and transporter pathways

European psychiatry, 2014, Vol.29, p.1-1

Luykx, J

2014

Volltextzugriff (PDF)

Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study

International journal of epidemiology, 2019-10, Vol.48 (5), p.1505-1514

2019

Volltextzugriff (PDF)

Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of 1H-MRS findings

Neuroscience and biobehavioral reviews, 2012, Vol.36 (1), p.198-205

2012

Volltextzugriff (PDF)

Comprehensive analyses of RNA-seq and genome-wide data point to enrichment of neuronal cell type subsets in neuropsychiatric disorders

Molecular psychiatry, 2022-02, Vol.27 (2), p.947-955

2022

Volltextzugriff (PDF)

Dopamine D2 receptor antagonism of antipsychotics and the risk of death due to choking

Psychiatry research, 2024-09, Vol.339, p.116012, Article 116012

2024

Volltextzugriff (PDF)

Antipsychotic discontinuation: mind the patient and the real-world evidence

The Lancet. Psychiatry, 2021-07, Vol.8 (7), p.555-557

2021

Volltextzugriff (PDF)

Sustainability in Dutch and Flemish mental healthcare: A descriptive and comparative study

European psychiatry, 2023-03, Vol.66 (S1), p.S752-S752

2023

Volltextzugriff (PDF)

Polygenic risk scores for genetic counseling in psychiatry: Lessons learned from other fields of medicine

Neuroscience and biobehavioral reviews, 2021-02, Vol.121, p.119-127

2021

Volltextzugriff (PDF)

1 – 25 von 258

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(222)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Associations between polygenic loading, psychosis liability, and clozapine use

Psychotropic drugs and the environment: a comprehensive analysis of surface water concentrations and associated risks

The genetic basis of major depression

Stratified psychiatry: Tomorrow's precision psychiatry?

In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine

Clozapine as a first‐ or second‐line treatment in schizophrenia: a systematic review and meta‐analysis

Isolated nausea and vomiting as the cardinal presenting symptoms of clozapine-induced myocarditis: a case report

Morbidity and mortality in schizophrenia with comorbid substance use disorders

Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials

Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts

Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia

Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia

Are psychiatric disorders risk factors for COVID-19 susceptibility and severity? a two-sample, bidirectional, univariable, and multivariable Mendelian Randomization study

Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid

Adjusting for population stratification in polygenic risk score analyses: a guide for model specifications in the UK Biobank

Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians’ attitudes to sociocultural differences between patients across the globe

EPA-0868 – Genetic determinants of monoamine turnover in human cerebrospinal fluid: associations with 5-HT seasonality and mood symptoms

EPA-0871 – Genome-wide association study of NMDA receptor coagonists in cerebrospinal fluid and plasma identifies metabolic and transporter pathways

Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study

Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of 1H-MRS findings

Comprehensive analyses of RNA-seq and genome-wide data point to enrichment of neuronal cell type subsets in neuropsychiatric disorders

Dopamine D2 receptor antagonism of antipsychotics and the risk of death due to choking

Antipsychotic discontinuation: mind the patient and the real-world evidence

Sustainability in Dutch and Flemish mental healthcare: A descriptive and comparative study

Polygenic risk scores for genetic counseling in psychiatry: Lessons learned from other fields of medicine

Suchergebnisse filtern